JERUSALEM, Aug. 2 (Xinhua) -- Israel's Teva Pharmaceutical, a world-leading generic drugmaker, and the northern Israel Institute of Technology (Technion) announced collaboration on Sunday, to promote innovative R&D in the fields of cancer and neurobiology.
According to a joint statement issued by Teva and the Technion, the collaboration is a significant link in a chain of collaborations Teva has initiated with leading academic institutions, including the Tel Aviv University, the Weizmann Institute of Science, and more.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
